Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.31 | 1.73 |
PEG Ratio (TTM) | 0.05 | -2.10 |
P/S Ratio (TTM) | N/A | 1.12 |
P/B Ratio (TTM) | 8.85 | 1.90 |
P/FCF Ratio (TTM) | -18.59 | 0.79 |
Price to 5YR AVG Earnings Ratio | N/A | -10.25 |
Price to 5YR AVG FCF Ratio | N/A | 6.11 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -43.56% | -6.04% |
ROE (TTM) | -456.67% | -56.34% |
Net Profit Margin (TTM) | N/A | 0.97% |
ROIC 5YR AVG | N/A | -2.34% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -92.09% | 857.04% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -195.55% | 21,089.14% | N/A |
Cash Flow | -23,864.92% | -124,635.29% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.50 | 2.04 |
Quick Ratio (TTM) | 3.34 | 1.89 |
D/E Ratio (TTM) | 4.86 | 1.47 |
Interest Coverage (TTM) | -7.54 | 1.84 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 1.34 |
LTL to 5YR AVG FCF | N/A | -69.80 |
Shares Outstanding Growth 5YR AVG | N/A | 3.60% |